Allogene Therapeutics SG&A Expense (Quarterly) Insights

Allogene Therapeutics Inc (ALLO)

3.08 +0.11 (+3.70%) USD | NASDAQ | May 03, 15:55

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	17.22M
September 30, 2023	17.04M
June 30, 2023	18.52M
March 31, 2023	18.88M
December 31, 2022	21.00M
September 30, 2022	18.90M
June 30, 2022	19.51M
March 31, 2022	19.90M
December 31, 2021	19.96M
September 30, 2021	19.00M
June 30, 2021	18.78M
March 31, 2021	16.36M

Date	Value
December 31, 2020	17.13M
September 30, 2020	16.62M
June 30, 2020	15.86M
March 31, 2020	15.64M
December 31, 2019	15.21M
September 30, 2019	15.02M
June 30, 2019	14.19M
March 31, 2019	13.06M
December 31, 2018	14.54M
September 30, 2018	11.32M
June 30, 2018	12.53M
March 31, 2018	2.597M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

14.19M

Minimum

Jun 2019

21.00M

Maximum

Dec 2022

17.62M

Average

17.22M

Median

Dec 2023

SG&A Expense (Quarterly) Benchmarks